Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

35

Revenue 2017

Symbicort

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Symbicort was produced by AstraZeneca and Astellas.

Soriot says pipeline will speed recovery at AZ

Soriot says pipeline will speed recovery at AZ esomeprazole). Asthma and chronic obstructive pulmonary disease (COPD) treatment Symbicort (budesonide and formoterol) had another strong quarter, rising 11 per cent to $976m, but will face increasing competition in the marketplace

Novartis tops leaderboard at PM Society Digital Media Awards

Novartis tops leaderboard at PM Society Digital Media Awards Close behind Ruder Finn was Digitas Health, which picked up two awards, taking home the craft award – mobile for its Symbicort Mobile App on behalf of AstraZeneca.  .

Novartis' combo COPD inhaler cleared in EU

Novartis' combo COPD inhaler cleared in EU Advair (salmeterol and fluticasone) and AstraZeneca's $3bn Symbicort (formoterol and budesonide).

FDA guidance clears path for Advair generics

FDA guidance clears path for Advair generics The FDA's new draft guidance provides a simplified framework for companies trying to develop generics of Advair as well as other combination inhaled medicines such as AstraZeneca's Symbicort ... Moreover, it looks like the FDA will only require bridging

AstraZeneca boosts R&D prospects with Pearl acquisition

AstraZeneca boosts R&D prospects with Pearl acquisition AZ's CEO Soriot said the acquisition of Pearl complemented the company's current respiratory portfolio, which is currently dominated by Symbicort and Pulmicort, although both products are set to face

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics